期刊
PLANTA MEDICA
卷 78, 期 4, 页码 393-399出版社
GEORG THIEME VERLAG KG
DOI: 10.1055/s-0031-1280404
关键词
enzyme inhibition; alpha-amylase; alpha-glucosidase; cerrado; Brazilian savannah; diabetes
资金
- Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)
- Fundacao de Empreendimentos Cientificos e Tecnologicos (FINATEC)
- Coordenacao de Aperfeioamento de Pessoal de Nivel Superior (CAPES)
Diabetes mellitus is the most common disease in the world. One therapeutic approach for treating diabetes is inhibition of alpha-amylase and alpha-glucosidase activities to reduce postprandial blood glucose levels. In vitro tests showed that several plant extracts from Brazilian cerrado species can inhibit the activity of alpha-amylase and alpha-glucosidase. The extracts of Eugenia dysenterica, Stryphnodendron adstringens, Pouteria caimito, Pouteria ramiflora, and Pouteria torta showed strong alpha-amylase and alpha-glucosidase inhibitory activity. Eugenia dysenterica, P. caimito, P. ramiflora, and P. torta aqueous extracts exerted the highest activity against alpha-amylase (IC50 values of 14.93, 13.6, 7.08, and 5.67 mu g/mL, respectively) and alpha-glucosidase (IC50 values of 0.46, 2.58, 0.35, and 0.22 mu g/mL, respectively). Stryphnodendron adstringens ethanol extract also exhibited inhibitory activity against both enzymes (IC50 1.86 mu g/mL against alpha-amylase and 0.61 mu g/mL against alpha-glucosidase). The results suggest that the activity of these cerrado plants on alpha-amylase and alpha-glucosidase represents a potential tool for development of new strategies for treatment of diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据